James G. Stevenson, PharmD, FASHP

With the introduction of biosimilars in the United States, there are several significant issues that will challenge those involved in formulary committees and benefit plans, as well as prescribers and pharmacists.

Pharmacists' communication activities are critical to improving and maintaining a positive image among the public; therefore, a media plan should be in place in order to reach both broad and narrowly defined audiences.

Description of strategies that employers can consider to better manage their PBM relationship to optimize their pharmacy benefit costs.